Ads
related to: radiated iodine treatment thyroid cancer pros and cons- Learn About GEP-NETs
HCPs, Get Info About The Condition.
Visit a Product Site About GEP-NETs
- Find A Treatment Center
Use This Treatment Site Locator
To Find Nearest Treatment Center.
- FDA-Approved Treatment
Regimen For Somatostatin Receptor-
Positive GEP-NETs. HCPs Resources.
- Patient Resources
View Resources For Your Patients.
Find Helpful Support Information.
- Clinical Data
Access Clinical Trial Data.
View Efficacy Information.
- Treatment Safety
Read The Rx Safety Profile.
Visit The Website To Learn More.
- Learn About GEP-NETs
cancer.osu.edu has been visited by 10K+ users in the past month
consumereview.org has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
Radioactive iodine (iodine-131) alone can potentially worsen thyrotoxicosis in the first few days after treatment. One side effect of treatment is an initial period of a few days of increased hyperthyroid symptoms. This occurs because when the radioactive iodine destroys the thyroid cells, they can release thyroid hormone into the blood stream.
The patient swallows a radioisotope of iodine in the form of capsule or fluid, and the absorption (uptake) of this radiotracer by the thyroid is studied after 4–6 hours and after 24 hours with the aid of a scintillation counter. The dose is typically 0.15–0.37 MBq (4–10 μCi) of 131 I iodide, or 3.7–7.4 MBq (100–200 μCi) of 123 I ...
Thyroid cancer accounts for less than 1% of cancer cases and deaths in the UK. Around 2,700 people were diagnosed with thyroid cancer in the UK in 2011, and around 370 people died from the disease in 2012. [70] However, in South Korea, thyroid cancer was the 5th most prevalent cancer, which accounted for 7.7% of new cancer cases in 2020. [71]
The beta radiation released damages both normal thyroid tissue and any thyroid cancer that behaves like normal thyroid in taking up iodine, so providing the therapeutic effect, whilst most of the gamma radiation escapes the patient's body. [7] Most of the iodine not taken up by thyroid tissue is excreted through the kidneys into the urine.
Most studies of very-high-dose I-131 for treatment of Graves disease have failed to find any increase in thyroid cancer, even though there is linear increase in thyroid cancer risk with I-131 absorption at moderate doses. [12] Internal exposure of the public is controlled by regulatory limits on the radioactive content of food and water.
Theranostics originated in the field of nuclear medicine; iodine isotope 131 for the diagnostic study and treatment of thyroid cancer was one of its earliest applications. [7] Nuclear medicine encompasses various substances, either alone or in combination, that can be used for diagnostic imaging and targeted therapy.